125 related articles for article (PubMed ID: 17877636)
1. Bioenergetic and oxidative effects of free 3-nitrotyrosine in culture: selective vulnerability of dopaminergic neurons and increased sensitivity of non-dopaminergic neurons to dopamine oxidation.
Ma TC; Mihm MJ; Bauer JA; Hoyt KR
J Neurochem; 2007 Oct; 103(1):131-44. PubMed ID: 17877636
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic neurons are preferentially sensitive to long-term rotenone toxicity in primary cell culture.
Radad K; Gille G; Rausch WD
Toxicol In Vitro; 2008 Feb; 22(1):68-74. PubMed ID: 17923380
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10.
Moon Y; Lee KH; Park JH; Geum D; Kim K
J Neurochem; 2005 Jun; 93(5):1199-208. PubMed ID: 15934940
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
[TBL] [Abstract][Full Text] [Related]
5. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
Chinta SJ; Andersen JK
Free Radic Biol Med; 2006 Nov; 41(9):1442-8. PubMed ID: 17023271
[TBL] [Abstract][Full Text] [Related]
6. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2007 Nov; 85(14):3109-17. PubMed ID: 17868147
[TBL] [Abstract][Full Text] [Related]
7. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment.
Milusheva E; Baranyi M; Kittel A; Sperlágh B; Vizi ES
Free Radic Biol Med; 2005 Jul; 39(1):133-42. PubMed ID: 15925285
[TBL] [Abstract][Full Text] [Related]
9. Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism.
Sai Y; Wu Q; Le W; Ye F; Li Y; Dong Z
Toxicol In Vitro; 2008 Sep; 22(6):1461-8. PubMed ID: 18579341
[TBL] [Abstract][Full Text] [Related]
10. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein.
Park SS; Schulz EM; Lee D
Eur J Neurosci; 2007 Dec; 26(11):3104-12. PubMed ID: 18005066
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxic mechanisms of 2,9-dimethyl-beta-carbolinium ion in primary dopaminergic culture.
Hamann J; Rommelspacher H; Storch A; Reichmann H; Gille G
J Neurochem; 2006 Aug; 98(4):1185-99. PubMed ID: 16787411
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
14. In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation.
Papanikolaou T; Amano T; Lennington J; Sink K; Farrar AM; Salamone J; Yang X; Conover JC
Eur J Neurosci; 2009 Jun; 29(12):2264-75. PubMed ID: 19508691
[TBL] [Abstract][Full Text] [Related]
15. Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress.
Mytilineou C; Walker RH; JnoBaptiste R; Olanow CW
J Pharmacol Exp Ther; 2003 Feb; 304(2):792-800. PubMed ID: 12538835
[TBL] [Abstract][Full Text] [Related]
16. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.
Lin CH; Huang JY; Ching CH; Chuang JI
J Pineal Res; 2008 Mar; 44(2):205-13. PubMed ID: 18289173
[TBL] [Abstract][Full Text] [Related]
17. Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity.
Ajjimaporn A; Shavali S; Ebadi M; Govitrapong P
Brain Res Bull; 2008 Dec; 77(6):361-6. PubMed ID: 18852031
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effects of vitamin A supplementation on adult rat substantia nigra and striatum redox and bioenergetic states: mitochondrial impairment, increased 3-nitrotyrosine and alpha-synuclein, but decreased D2 receptor contents.
de Oliveira MR; Oliveira MW; Behr GA; Hoff ML; da Rocha RF; Moreira JC
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):353-62. PubMed ID: 19166897
[TBL] [Abstract][Full Text] [Related]
19. Effects of iptakalim on rotenone-induced cytotoxicity and dopamine release from PC12 cells.
Yang Y; Liu X; Ding JH; Sun J; Long Y; Wang F; Yao HH; Hu G
Neurosci Lett; 2004 Aug; 366(1):53-7. PubMed ID: 15265589
[TBL] [Abstract][Full Text] [Related]
20. 3-Nitrotyrosine-dependent dopaminergic neurotoxicity following direct nigral administration of a peroxynitrite but not a nitric oxide donor.
Iravani MM; Haddon CO; Rose S; Jenner P
Brain Res; 2006 Jan; 1067(1):256-62. PubMed ID: 16388785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
